Hope for chronic skin pain: drug shows promise in small trial
Disease control
Completed
This study tested a drug called apremilast (Otezla) in 6 people with a chronic, painful skin condition called erythema multiforme that did not get better with standard treatments. The goal was to see if the drug could reduce the number of flare-ups and pain over 6 months. The stu…
Phase: PHASE2 • Sponsor: Robert Micheletti • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC